Table 3. Risk of MACE for patients with different cumulative prescription days of ARB.

Variables	N	Event, n	Adjusted HR (95% CI) a , b , c	P-value
Duration				<0.001
non-users	1061	497	1
1–90 days	224	121	1.00(0.81–1.23)
91–365 days	237	128	0.87(0.71–1.08)
366–730 days	136	64	0.72(0.55–0.95)*
731–1095 days	78	30	0.51(0.35–0.75)***
1096–1460 days	42	10	0.34(0.18–0.64)*
1460–1825 days	22	1	0.06(0.01–0.45)*

^a HR = hazard ratio; CI = confidence interval.

^b Adjusted for gender, age group, and comorbidities.

^c *P < 0.05; ***P < 0.001.